Affinor Growers Inc. Appoints Dr. Hyder Khoja, Biotechnology and Sustainable Agriculture Innovator, as an Advisor to the Company

Affinor Growers Inc. (CSE: AFI) (OTC Pink: RSSFF) is pleased to announce the appointment of Dr. Hyder Khoja as an advisor to the Company. Dr. Hyder Khoja has over two decades of experience founding, leading, and advising life-science ventures across pharmaceuticals, nutraceuticals, functional medicine, psychedelics, cannabis, agriculture, sustainability, and renewable energy. His work spans molecular biology, drug discovery, plant sciences, and bioeconomy strategy, with a focus on translating scientific ideas into commercially relevant technologies. Dr. Khoja has developed proprietary intellectual property in mycelium-based biomedical platforms and rapid-acting anxiolytic therapeutics; pursued major research funding, including a shortlisted US$50 million U.S. Department of Energy grant; and established research environments with GMP- and GLP-certified capabilities supported by rigorous regulatory standards.

Pursuant to the consulting agreement entered into between the Company and Dr. Khoja, and subject to the Company's Stock Option Plan, the Company will grant 500,000 stock options to Dr. Khoja in connection with the advisory services to be provided to the Company. Each Option is exercisable to acquire one common share of the Company at an exercise price of $0.05 per Share, for a period of 36 months from the date of grant. The Consulting Agreement and the grant of Options thereunder are subject to the policies of the Canadian Securities Exchange.

About Affinor Growers Inc. Affinor Growers Inc. is focused on the design, development and commercialization of vertical farming technology for both indoor and outdoor greenhouse applications. The Company is developing processes, methods, and models to cultivate crops such as strawberries and leafy greens using efficient vertical growing systems intended to reduce land, water, and energy requirements while supporting year-round production.